Pirtobrutinib significantly improves PFS in patients with treatment-naïve CLL/SLL
“Promising” early-phase results seen with KLN-1010, an off-the-shelf in vivo CAR-T for myeloma
Teclistamab plus daratumumab improves survival compared with SOC triplet therapy in relapsed/refractory MM
Phase 3 study finds fixed-duration treatment non-inferior to continuous treatment in CLL
Extended MorningSun study results show ‘promising’ survival with subcutaneous mosunetuzumab

Join SOHO

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Leukemia

Leukemia News SOHO 2025 News Video Interviews

Drs. Jabbour, Logan, and Aldoss discuss treatment advancements in ALL

by SOHO Insider Editors
December 1, 2025
0 Comments

Leukemia News

FDA approves ziftomenib for relapsed or refractory NMP1-mutated AML

by Leah Sherwood
November 14, 2025
0 Comments

Leukemia News SOHO 2025

Dr. Jabbour discusses investigational menin inhibitor bleximenib

by Leah Sherwood
November 3, 2025
0 Comments

Leukemia News SOHO 2025 Leukemia Chronic Lymphocytic Leukemia

Obesity increases infection risk in CLL for patients treated with a BTKi

by Leah Sherwood
October 31, 2025
0 Comments

Leukemia News SOHO 2025 News Video Interviews

How does MRD guide treatment decisions in ALL?

by SOHO Insider Editors
October 28, 2025
0 Comments

Leukemia News SOHO 2025 Educational Resources Acute Myeloid Leukemia Meetings / Conferences News

Future Role of CPX-351 and CPX-351-Based Combinations

by SOHO Insider Editors
October 15, 2025
0 Comments

Leukemia News SOHO 2025 Leukemia Acute Lymphoblastic Leukemia Meetings / Conferences Video Interviews

Can sequencing chemotherapy and immunotherapy transform ALL treatment?

by Leah Sherwood
October 13, 2025
0 Comments

Leukemia News SOHO 2025 Meetings / Conferences News Video Interviews

Drs. Kantarjian and Short detail ALL treatment shift at SOHO 2025

by Leah Sherwood
October 13, 2025
0 Comments

Leukemia News SOHO 2025

Drs. Kantarjian and Mauro discuss ELVN-001 in CML

by SOHO Insider Editors
October 10, 2025
0 Comments

Leukemia News SOHO 2025

Early-phase CLL trial shows bexobrutideg well tolerated

by Leah Sherwood
October 3, 2025
0 Comments

1
2

Top Categories

Cellular Therapy

13

Leukemia

71

Lymphoma

67

Multiple Myeloma

63

Myelodysplastic Syndromes

24

Myeloproliferative Neoplasms

12

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Leukemia

Drs. Jabbour, Logan, and Aldoss discuss treatment advancements in ALL

FDA approves ziftomenib for relapsed or refractory NMP1-mutated AML

Dr. Jabbour discusses investigational menin inhibitor bleximenib

Obesity increases infection risk in CLL for patients treated with a BTKi

How does MRD guide treatment decisions in ALL?

Future Role of CPX-351 and CPX-351-Based Combinations

Can sequencing chemotherapy and immunotherapy transform ALL treatment?

Drs. Kantarjian and Short detail ALL treatment shift at SOHO 2025

Drs. Kantarjian and Mauro discuss ELVN-001 in CML

Early-phase CLL trial shows bexobrutideg well tolerated

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

Pirtobrutinib significantly improves PFS in patients with treatment-naïve CLL/SLL

“Promising” early-phase results seen with KLN-1010, an off-the-shelf in vivo CAR-T for myeloma

Teclistamab plus daratumumab improves survival compared with SOC triplet therapy in relapsed/refractory MM

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

Leukemia

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms